Earnings preview: Medicare Advantage to drive Humana’s Q4 growth
The quarterly performance of healthcare companies will be closely watched this season, considering the hectic M&A activity the sector has...
Health Care
Earnings Preview: New drugs to propel Eli Lilly forward
Eli Lilly and Company (LLY) is scheduled to report earnings results for the fourth quarter of 2018 on February 6,...
Alexion Pharma stock jumps after Q4 results top expectations
Benefitting from the continued sales growth across all markets, led by cancer drug Soliris, Alexion Pharma (ALXN) Monday reported a...
Earnings Preview: Soliris to drive Alexion’s Q4 topline
Alexion Pharmaceuticals Inc. (ALXN) is set to report fourth-quarter 2018 earnings results on Monday, February 4, before market open. Wall...
Earnings preview: HIV to drive topline growth for Gilead Sciences in Q4
Biotechnology company Gilead Sciences (GILD) is scheduled to report fourth-quarter earnings results after the closing bell on Monday, February 4....
Merck’s stock gains after Q4 results beat estimates
Merck’s (MRK) shares climbed over 3% in morning trade on Friday after the company topped revenue and earnings expectations for...
Cigna’s stock falls despite Q4 results beat
Cigna Corporation (CI) topped market expectations on revenue and earnings for the fourth quarter of 2018. Despite the beat, the...
Celgene posts upbeat Q4 results, guidance
Celgene Corp. (CELG) swung to a profit in the fourth quarter from a loss last year, helped by lower research...
Earnings preview: Merck to ride the wave of expanding oncology portfolio in Q4
The general market sentiment on Merck & Co. (MRK) is quite bullish ahead of the drug maker’s fourth-quarter earnings report....
Anthem’s stock gains 6% after Q4 results top expectations
Anthem Inc. (ANTM) reported better-than-expected revenue and earnings for the fourth quarter of 2018, sending the stock up over 6%...
Amgen swings to profit in Q4, beats estimates
Amgen (AMGN) swung to a profit in the fourth quarter from a loss last year, helped by higher revenues, lower...
Illumina Q4 earnings miss estimates
Gene-sequencing firm Illumina (NASDAQ: ILMN) reported mixed Q4 results. The company failed to beat street estimates on the earnings front...
Biogen’s Q4 results beat estimates; revenues up 7%
Biogen Inc. (BIIB) reported revenue and earnings that surpassed market expectations for the fourth quarter of 2018. The stock was...
Allergan’s stock falls after company reports loss in Q4
Allergan plc (AGN) saw its shares drop 4.2% in premarket hours on Tuesday after the company reported a GAAP net...
Earnings: Pfizer edges past Q4 estimates, shares dip on weak outlook
Pfizer (PFE) reported a better-than-expected 2% increase in fourth-quarter revenues to $13.9 billion. Earnings rose to 64 cents per share...
Earnings preview: Botox to drive Allergan’s growth in Q4
Allergan plc (AGN) is set to report its fourth-quarter 2018 earnings results on Tuesday, January 29, before market open. Analysts...
Amgen set to report Q4 earnings on Jan. 29. What’s in store?
Amgen (AMGN) will be reporting its fourth quarter and full-year 2018 earnings results on Tuesday, January 29 after market closes....
Earnings Preview: All eyes on the Pfizer-Glaxo JV
Pfizer Inc. (PFE) is scheduled to report earnings results for the fourth quarter of 2018 on Tuesday, January 29, before...
AbbVie slips to loss in Q4, misses estimates
AbbVie Inc. (ABBV) slipped to a loss in the fourth quarter from a profit last year, due to the inclusion...
Bristol-Myers Squibb reports Q4 earnings on Jan 24. What to expect
Only two weeks after announcing its massive acquisition of Celgene Corporation, drug-maker Bristol-Myers Squibb (BMY) is all set to report...
Abbott Laboratories swings to profit in Q4, beats estimates
Abbott Laboratories (ABT) swung to a profit in the fourth quarter from a loss last year, helped by a decline...